Advertisement
Advertisement
NPCE
Neuropace, Inc. Common Stock
14.81
USDSponsored
+0.13
+0.89%
Jul 24, 16:00 UTC -4
Closed
After-Market
14.80
-0.01
-0.07%
NPCE Earnings Reports
Positive Surprise Ratio
NPCE beat 14 of 21 last estimates.
67%
Next Report
Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$23.05M
/-$0.21
Implied change from Q1 26 (Revenue/ EPS)
+4.47%
/+5.00%
Implied change from Q2 25 (Revenue/ EPS)
-1.98%
/-19.23%
Neuropace, Inc. Common Stock earnings per share and revenue
On May 12, 2026, NPCE reported earnings of -0.20 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 14.75% surprise. Revenue reached 22.07 million, compared to an expected 22.08 million, with a -0.04% difference. The market reacted with a +0.06% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 23.05 million USD, implying an increase of 5.00% EPS, and increase of 4.47% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jul 14, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+23.75%
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.53%
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.27%
FAQ
What were Neuropace, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Neuropace, Inc. Common Stock reported EPS of -$0.20, beating estimates by 14.75%, and revenue of $22.07M, -0.04% below expectations.
How did the market react to Neuropace, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 0.06%, changed from $15.80 before the earnings release to $15.81 the day after.
When is Neuropace, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 06, 2026.
What are the forecasts for Neuropace, Inc. Common Stock's next earnings report?
Based on 9
analysts, Neuropace, Inc. Common Stock is expected to report EPS of -$0.21 and revenue of $23.05M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement